52-Week Phase 3 Study Found Investigational Drug Dapagliflozin Plus Metformin Similar To Glipizide Plus Metformin In Improving HbA1c

Podiatry Arena 52-Week Phase 3 Study Found Investigational Drug Dapagliflozin Plus Metformin Similar To Glipizide Plus Metformin In Improving HbA1c

Welcome to the Podiatry Arena forums, for communication between foot health professionals about podiatry and related topics.

You are currently viewing our podiatry forum as a guest which gives you limited access to view all podiatry discussions and access our other features. By joining our free global community of Podiatrists and other interested foot health care professionals you will have access to post podiatry topics (answer and ask questions), communicate privately with other members (PM), upload content, view attachments, receive a weekly email update of new discussions, earn CPD points and access many other special features. Registered users do not get displayed the advertisments in posted messages. Registration is fast, simple and absolutely free so please, join our global Podiatry community today!

If you have any problems with the registration process or your account login, please contact contact us.

52-Week Phase 3 Study Found Investigational Drug Dapagliflozin Plus Metformin Similar To Glipizide Plus Metformin In Improving HbA1c

Submit Thread >

< Submit Thread

Thread Tools

Display Modes

25th September 2010, 05:10 AM

RSSFeedBot RSSFeedBot is offline

I, Robot

About:

Join Date: Jul 2008

Posts: 10,128

Join Date: Jul 2008

Marketplace reputation 0% (0)

CPD Points: 1

Thanks: 0

Thanked 19 Times in 19 Posts

52-Week Phase 3 Study Found Investigational Drug Dapagliflozin Plus Metformin Similar To Glipizide Plus Metformin In Improving HbA1c

Podiatry Arena members do not see these ads

Bristol-Myers Squibb Company (NYSE: BMY) and AstraZeneca (NYSE: AZN) announced results from a randomized, double-blind Phase 3 clinical study in adults with type 2 diabetes inadequately controlled on metformin therapy alone...

More...

Sponsored Links

« Previous Thread | Next Thread »

Thread Tools
Show Printable Version Email this Page
Display Modes
Linear Mode Switch to Hybrid Mode Switch to Threaded Mode

Posting Rules
You may not post new threads You may not post replies You may not post attachments You may not edit your posts	vB code is On Smilies are On [IMG] code is On HTML code is On

Forum Jump

Translate This Page

Similar Threads

Thread	Thread Starter	Forum	Replies	Last Post
Investigational Drug Dapagliflozin For Diabetes Meets Study Goals After 24-Week Phase 3 Study	RSSFeedBot	Latest Diabetes Medicine Research & News	0	20th September 2010 01:10 PM
How Metformin Works In Diabetes Could Lead To Wider Use Of The Drug	RSSFeedBot	Latest Diabetes Medicine Research & News	0	5th May 2010 09:50 AM
Treatment With Insulin Or Metformin Does Not Reduce Inflammatory Biomarkers For Patients With Diabetes	RSSFeedBot	Latest Diabetes Medicine Research & News	0	17th September 2009 04:20 AM
PrandiMet(R), First Repaglinide And Metformin HCl Fixed Dose Combination Therapy, Now Available In The United States	RSSFeedBot	Latest Diabetes Medicine Research & News	0	8th February 2009 05:10 AM
Similar drug-name pairs nearly double 2004 tally	NewsBot	American Medical Association News	0	6th April 2008 07:00 PM

New To Site?	Need Help?
Register to Participate View Forum Leaders Contact Us	Frequently Asked Questions Did you forget your password? Mark Forums Read

Finding your way around:

Browse the forums.

Search the site.

Browse the tags.

Search the tags.

All times are GMT -7. The time now is 08:43 AM.

User Name		Remember Me?
Password